Observational studyRMD open2025

Cancer recurrence risk with bDMARD treatment in patients with rheumatoid arthritis and a history of cancer: a nationwide Danish register-based cohort study.

Rasmus Westermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.